Business Description
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS
ISIN : TREONCO00026
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.71 | |||||
Equity-to-Asset | 0.64 | |||||
Debt-to-Equity | 0.32 | |||||
Debt-to-EBITDA | -0.97 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 16.2 | |||||
Beneish M-Score | -2.63 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 33.7 | |||||
3-Year Book Growth Rate | 46.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 23.17 | |||||
9-Day RSI | 31.59 | |||||
14-Day RSI | 38.08 | |||||
6-1 Month Momentum % | -17.41 | |||||
12-1 Month Momentum % | -16.19 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.81 | |||||
Quick Ratio | 1.06 | |||||
Cash Ratio | 0.45 | |||||
Days Inventory | 100.01 | |||||
Days Sales Outstanding | 79.03 | |||||
Days Payable | 23.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.29 | |||||
Shareholder Yield % | -0.22 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 12.64 | |||||
Operating Margin % | -28.74 | |||||
Net Margin % | -44.11 | |||||
FCF Margin % | -11.6 | |||||
ROE % | -60.73 | |||||
ROA % | -42.01 | |||||
ROIC % | -32.96 | |||||
3-Year ROIIC % | -47.62 | |||||
ROC (Joel Greenblatt) % | -70.5 | |||||
ROCE % | -58.9 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 0.76 | |||||
PB Ratio | 15.79 | |||||
Price-to-Tangible-Book | 15.18 | |||||
Price-to-Free-Cash-Flow | 14.02 | |||||
Price-to-Operating-Cash-Flow | 6.44 | |||||
EV-to-EBIT | -28.41 | |||||
EV-to-EBITDA | -45.77 | |||||
EV-to-Revenue | 12.81 | |||||
EV-to-FCF | -117.53 | |||||
Price-to-Net-Current-Asset-Value | 44.17 | |||||
Earnings Yield (Greenblatt) % | -3.52 | |||||
FCF Yield % | -0.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₺) | 265.795 | ||
EPS (TTM) (₺) | -13.247 | ||
Beta | 0 | ||
Volatility % | 74.73 | ||
14-Day RSI | 38.08 | ||
14-Day ATR (₺) | 14.789935 | ||
20-Day SMA (₺) | 176.335 | ||
12-1 Month Momentum % | -16.19 | ||
52-Week Range (₺) | 123.9 - 268 | ||
Shares Outstanding (Mil) | 23.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Stock Events
Event | Date | Price(₺) | ||
---|---|---|---|---|
No Event Data |
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Frequently Asked Questions
What is Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS(IST:ONCSM)'s stock price today?
When is next earnings date of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS(IST:ONCSM)?
Does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS(IST:ONCSM) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |